Mannkind (MNKD) Shares Outstanding (Weighted Average) (2010 - 2026)

Mannkind (MNKD) reported Shares Outstanding (Weighted Average) of $308.3 million for Q1 2026, up 1.58% year-over-year from $303.5 million in Q1 2025, and up 0.86% quarter-over-quarter from $305.6 million in Q4 2025.

Mannkind (MNKD) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $308.3 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $308.3 million, up 1.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.3 million (up 1.58% YoY), and the FY2025 annual result was $305.6 million, up 11.38% from the prior year.
  • Shares Outstanding (Weighted Average) grew to $308.3 million in Q1 2026 per MNKD's latest filing, from $305.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $308.3 million in Q1 2026 and troughed at $251.9 million in Q1 2022.
  • A 5-year average of $276.6 million and a median of $270.4 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) rose 12.25% in 2025, then grew 1.58% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $257.1 million in 2022, then gained by 3.86% to $267.0 million in 2023, then gained by 2.77% to $274.4 million in 2024, then grew by 11.38% to $305.6 million in 2025, then gained by 0.86% to $308.3 million in 2026.
  • Business Quant data shows MNKD's Shares Outstanding (Weighted Average) at $308.3 million in Q1 2026, $305.6 million in Q4 2025, and $306.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 185,491.37 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 4,489.46 Bn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 118.76 Bn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 417.01 Bn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 254.10 Mn
9 Abivax 90.15 Bn 90.15 Bn - 928.40 Mn
10 Mannkind 1.13 Bn 995.19 Mn 82.66 Mn 308.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 308.27 Mn
Dec 31, 2025 305.64 Mn
Sep 30, 2025 306.81 Mn
Jun 30, 2025 304.95 Mn
Mar 31, 2025 303.48 Mn
Dec 31, 2024 274.42 Mn
Sep 30, 2024 275.00 Mn
Jun 30, 2024 273.06 Mn
Mar 31, 2024 270.36 Mn
Dec 31, 2023 267.01 Mn
Sep 30, 2023 266.13 Mn
Jun 30, 2023 265.63 Mn
Mar 31, 2023 263.97 Mn
Dec 31, 2022 257.09 Mn
Sep 30, 2022 254.97 Mn
Jun 30, 2022 253.64 Mn
Mar 31, 2022 251.89 Mn
Dec 31, 2021 249.24 Mn
Sep 30, 2021 248.62 Mn
Jun 30, 2021 247.97 Mn